A bunch of meaningless lies. To say that Novavax is going to lose between 1 and 2 billion when its sales are going to go well above 4 billion (the lower range than the company forecasts) is a fallacy based on an absolute distortion of reality and facts.
In 2021, with enormous expenses for the trials and especially for the production in the last quarter of a huge amount of antigen and adjuvant to advance inventory, the company spent 1 billion in the last quarter of 2021 and 2.8 billion throughout the year .
Novavax said expenses in 2022 would be lower. It must be taken into account that in 2021, the validation of the plants and the unification of the production systems to solve production problems entailed a considerable cost for the company. And once that has been fixed, those expenses do not occur again.
It is IMPOSSIBLE, as clumsy as Stan and the others may seem to us, for Novavax to lose between 1 and 2 billion on revenues of 4 between 4 and 5 billion.
Novavax has guaranteed orders of around 670 million doses. Even if ALL these doses were produced by Novavax and its partners, the production costs would be around 2.5 billion assuming a cost per dose of $4. But it is that, there are many millions of doses already produced and stored by Novavax, Biofrabri, Mabion and even by Fuji during the past year and these costs have already been passed on to the company's accounts.
In addition, for the time being, the doses that are delivered are produced by the IBS, so this does not imply an expense for Novavax.
And as seen in the 10K, only failure to obtain approval is grounds for canceling APAs.
The luck for the scoundrel who writes that rubbish, and takes advantage of it, is that, as always happens with negative arguments, he doesn't need to provide data, he just has to vomit that shit on a few lines and publish them...
Anyway... It's better to ignore such malicious lies.
Más información sobre este texto de origenPara obtener más información sobre la traducción, se necesita el texto de origen
Enviar comentarios
Paneles laterales
